PHILADELPHIA, Sept. 3, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Steven Kelly, President and Chief Executive Officer, will participate in the following upcoming conferences:
Baird 2024 Global Healthcare Conference
- Tuesday, September 10 at 12:50 PM ET
- New York, NY
H.C. Wainwright 26th Annual Global Investment Conference
- Wednesday, September 11 at 1:30 PM ET
- New York, NY
Chardan's 8th Annual Genetic Medicines Conference
- Monday, September 30 at 4:00 PM ET
- New York, NY
The Cell & Gene Meeting on the Mesa
- Monday, October 7 at 9:30 AM MST
- Phoenix, AZ
Live webcasts will be available on the Company's Investor Events webpage. A replay of the webcasts, when available, will be archived for a limited time following the event.
About Carisma
Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. Carisma is headquartered in Philadelphia, PA. For more information, please visit www.carismatx.com.
Investors:
Shveta Dighe
Head of Investor Relations
investors@carismatx.com
Media Contact:
Julia Stern
(763) 350-5223
jstern@realchemistry.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/carisma-therapeutics-to-present-at-upcoming-conferences-302235237.html
SOURCE Carisma Therapeutics Inc.
